Nath Biogene India Ltd. — Call Transcript 2024

May 6, 2024

==> picture [188 x 86] intentionally omitted <==

06[th] May 2024

The Manager-Listing The Manager-Listing

BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051

BSE Code-537291 NSE Code-NATHBIOGEN

Dear Sirs,

Subject- Intimation of Earning Conference Call.

This is to inform that the Company will hold Earning Conference Call on Thursday, 09[th] May 2024 at 04:00 PM IST.

Please find attached herewith the Conference Call Dial in Information.

Thanking You

For Nath Bio-Genes (India) Limited

Devinder Digitally signed by Devinder Gurusharan Gurusharan Khurana Date: 2024.05.06 17:14:29 Khurana +05'30'

Devinder Khurana Chief Financial Officer

==> picture [452 x 36] intentionally omitted <==

==> picture [130 x 72] intentionally omitted <==

==> picture [99 x 67] intentionally omitted <==

Nath Bio-Genes (I) Limited Q4 & FY24 Earnings Conference Call

Hosted by Go India Advisors

On Thursday, May 9, 2024 04:00 PM IST

Company Participants

Mr. Satish Kagliwal Managing Director

Mr. Devinder Khurana Chief Financial Officer Mr. Harish Pandey Business Lead Mr. Venkatesh Kulkarni Research Lead

Call in Details:

Pre-register to avoid wait time, join with Diamond Pass.

Registration link: CLICK HERE

Dial in Numbers: Please dial-in at least 5-10 minutes prior to the conference call schedule to ensure that you are connected to the call on time

Universal Dial-In Number +91 22 6280 1557/ +91 22 7115 8383

For further information, kindly contact:

Deepika Sharma Sheetal Khanduja deepika@goindiaadvisors.com sheetal@goindiaadvisors.com